Early time-of-day infusion of PD-1 inhibitor improves prognosis in advanced gastric cancer: a multicenter real-world study.

Qu Z, Guo X, Zhang S, Zhao Y, Hu Z, Ding W, Nomura S, Zhang Y, Wei X

Open source

DOI
10.3389/fimmu.2026.1945065
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1945065,
  title = {Early time-of-day infusion of PD-1 inhibitor improves prognosis in advanced gastric cancer: a multicenter real-world study.},
  author = {Qu Z and Guo X and Zhang S and Zhao Y and Hu Z and Ding W and Nomura S and Zhang Y and Wei X},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1945065},
  url = {https://doi.org/10.3389/fimmu.2026.1945065}
}

RIS

TY  - JOUR
TI  - Early time-of-day infusion of PD-1 inhibitor improves prognosis in advanced gastric cancer: a multicenter real-world study.
AU  - Qu Z
AU  - Guo X
AU  - Zhang S
AU  - Zhao Y
AU  - Hu Z
AU  - Ding W
AU  - Nomura S
AU  - Zhang Y
AU  - Wei X
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1945065
UR  - https://doi.org/10.3389/fimmu.2026.1945065
ER  - 

APA

Z, Q., X, G., S, Z., Y, Z., Z, H., W, D., S, N., Y, Z., & X, W. (2026). Early time-of-day infusion of PD-1 inhibitor improves prognosis in advanced gastric cancer: a multicenter real-world study.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1945065

Source records